ThinHeal is pleased to share that we have successfully obtained the Written Confirmation for Linaclotide active substance exported to the European Union. This certification demonstrates our ability to meet the regulatory requirements for peptide manufacturing and Quality Management aligned with EU standards.
Linaclotide is a guanylate cyclase-C agonist widely studied for gastrointestinal applications, including chronic constipation and IBS-C research. To ensure consistent product quality, ThinHeal implements comprehensive quality assurance systems and cGMP-aligned production practices at our manufacturing site in Shaoxing, Zhejiang, China. Each batch undergoes strict testing for purity, identity, and stability before release.
With this Written Confirmation, ThinHeal is prepared to support European partners with a dependable supply of Linaclotide active substance for research and development activities. We sincerely welcome inquiries regarding technical details, quotations, or long-term cooperation opportunities.
ThinHeal remains committed to continuous improvement in Peptide Technology and regulatory compliance, aiming to serve as a reliable global partner for high-quality active pharmaceutical ingredients.
Media Contact
Company Name: Hangzhou ThinHeal Pharma-Tech Co., Ltd
Email:Send Email
Country: China
Website: https://www.thinhealpeptide.com/